Ipca Laboratories (NSE:IPCALAB) 3-Year Revenue Growth Rate : 10.70% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Ipca Laboratories 3-Year Revenue Growth Rate?

Ipca Laboratories's Revenue per Share for the three months ended in Dec. 2023 was ₹80.91.

During the past 12 months, Ipca Laboratories's average Revenue per Share Growth Rate was 20.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 14.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Ipca Laboratories was 22.00% per year. The lowest was -1.60% per year. And the median was 15.70% per year.

Competitive Comparison of Ipca Laboratories's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ipca Laboratories's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's 3-Year Revenue Growth Rate falls into.

Ipca Laboratories 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Ipca Laboratories (NSE:IPCALAB) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Ipca Laboratories 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipca Laboratories (NSE:IPCALAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (NSE:IPCALAB) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

524494:India

Address

125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067

Website

https://www.ipca.com

Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (NSE:IPCALAB) Headlines

No Headlines